Despite being important clinical targets, it is not straightforward to reliably express recombinant trimeric αβγ GABA-A receptors (GABA A Rs) for high-throughput screening. This study therefore sought to devise a simple and reliable means of transiently expressing α1β1γ1 and α1β1γ2 GABA A Rs in HEK293 cells. Expression efficiencies resulting from 5 different transfection strategies were assessed by flow cytometry and pharmacological analysis using an anion-sensitive yellow fluorescent protein-based assay. PolyFect and Effectene, employed according to the manufacturers' instructions, conferred the strongest and most reliable expression of trimeric αβγ GABA A Rs. Functional analysis via the yellow fluorescent protein assay revealed dramatic differences in the pharmacological properties of γ1-and γ2-containing receptors, consistent with previous electrophysiological characterizations. The authors conclude that this method of expressing and screening recombinant GABA A Rs provides an effective means of discovering novel GABA A R modulators for use as therapeutic lead compounds and pharmacological probes. (Journal of Biomolecular Screening 2009:86-91) 
INTRODUCTION

G
ABA TyPE-A REcEPTOR cHlORIDE cHAnnElS (GABA A RS) are pentameric cys-loop receptors that mediate inhibitory neurotransmission in the central nervous system. Because mammalian GABA A Rs are constructed from a family of 16 subunits (α1-6, β1-3, γ1-3, δ, ε, π, θ), there is potentially an enormous variability in the stoichiometry of GABA A Rs at central nervous system synapses, 1,2 and it remains a major challenge to establish which subunit combinations are expressed at particular synapses and why. Isoform-specific GABA A R inhibitors could achieve this by eliminating the contribution of individual isoforms to the complex mix of conductances active at any one time in a neuron. However, currently available GABA A R pharmacological tools are not sufficiently selective for this purpose.
GABA A Rs are important drug targets for therapies directed at muscle relaxation, anxiolysis, epilepsy, sedation, and anesthesia and are emerging as therapeutic targets for a range of other indications. 3 There is, however, considerable scope for the development of new therapeutics with improved beneficial effects and fewer side effects.
It is therefore important, from both clinical and basic research standpoints, to discover novel GABA A R isoformspecific modulators. Indeed, several high-throughput screening (HTS) assays have been developed to screen anion-selective channels, with 2 of the most suitable being voltage-sensitive dyes (VSDs) and the anion-sensitive yellow fluorescent protein (yFP) mutant, yFP-I152l. 4 As VSDs are applied exogenously and thus taken up by all cells, stably expressing cell lines are essential for optimal assay sensitivity. In contrast, because transiently cotransfecting yFP-I152l and ion channel cDnAs result in a high rate of coexpression in individual cells, 5 the yFP-based assay does not require stably expressing cell lines to achieve full dynamic range. This is advantageous for screening compounds against numerous different GABA A R isoforms as it obviates the need to create and maintain a large range of stably expressing cell lines. However, it is not straightforward to reliably transiently express trimeric αβγ GABA A Rs in recombinant expression systems. 6 The aim of this study is to compare 5 transfection methods in an attempt to optimize the transient expression of αβγ GABA A Rs in HEK293 cells.
MATERIALS AND METHODS
Molecular constructs
Rat α1 and β1 subunit cDnAs were subcloned into the pIRES2-EGFP or pcDnA3.1 plasmid vectors, with each used as explained in the text. Rat γ1 and γ2S subunit cDnAs were subcloned into the pIRES2-EGFP plasmid vector. The pIRES-EGFP vector permits green fluorescent protein (GFP) fluorescence to be used as an indicator of the successful transfection of the inserted subunit, whereas the pcDnA3.1 vector transfects the inserted cDnA alone. The yFP-I152l cDnA was subcloned into the pcDnA3.1 vector. Its amino acid sequence was identical to that originally published.
7 yFP-I152l is relatively resistant to quench by cl -ions but is potently quenched by I -ions flowing into the cell through anion-permeant ion channels. 5, 7 It thus acts as a fluorescent reporter of GABA A R activation.
Cell culture and transfection
Experiments were performed on HEK293 cells cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and 1% penicillin/streptomycin. Approximately 5 × 10 5 cells suspended in 5 ml DMEM were plated into 60-mm culture dishes and were transfected when 40% to 80% confluent. yFP, α1, and β1 cDnAs were transfected in a 1:1:1 ratio, whereas yFP, α1, β1, and γ cDnAs were cotransfected in a 1:1:1:3 ratio. Four of the transfection procedures followed the manufacturers' instructions. The reagent quantities used for each of these procedures for transfection into 60-mm dishes are listed as follows: We also used a calcium phosphate precipitation transfection technique, as described in Sambrook et al., 8 using a total of 1 µg cDnA for each 60-mm dish.
Preparation of cells for experiments
Following termination of transfection, cells were trypsinized by adding 0.7 ml of 0.25% trypsin-EDTA solution (Gibco BRl), resuspended into DMEM, and 2.5 × 10 3 cells, suspended in 40 µl DMEM, were plated into each well of a transparent 384-well plate for fluorescence imaging experiments. cells were used in experiments 24 to 36 h later. Individual wells typically contained 2 × 10 4 cells at the time of the experiment. Approximately 1 h prior to commencement of experiments, culture media in 384-well plates were removed and replaced by 25 µl standard control solution, which contained (in mM) nacl 140, Kcl 5, cacl 2 2, Mgcl 2 1, HEPES 10, and glucose 10 (pH 7.4) using naOH. The naI test solution was similar in composition to nacl control solution except the nacl was replaced by equimolar naI. The effects of drugs were quantitated in the presence of an Ec 30 GABA concentration listed as follows for each subunit combination (in µM): α1β1, 0.6; α1β1γ1, 1.5; and α1β1γ2, 2.5.
For flow cytometry experiments, cells were maintained in a 5% cO 2 incubator for 24 to 36 h following termination of transfection. Approximately 1 h before experiments, cells were trypsinized as described above, resuspended in 5 ml DMEM, and centrifuged at 300 g for 5 min. The cell pellet was resuspended in 500 µl control solution maintained at 4 °c for up to 30 min until used in experiments. Each flow cytometry experiment employed approximately 5 × 10 6 cells.
Imaging experiments
The 384-well plates were placed onto a motorized stage (Prior ProScan II, Prior Scientific Instruments, cambridge, UK) of an Olympus IX51 inverted microscope, and cells were imaged with a 10× objective (UPlanFln, n.A. 0.30, Olympus, Tokyo, Japan). Illumination from a 100-W mercury arc lamp (HBO 103/2, Osram, Germany), passing through a yFP dichroic mirror (86002V2 JP4 c76444, Olympus), was used to excite yFP fluorescence. Fluorescence was imaged by a ccD camera (coolSnAP monochrome cf /Ol, Olympus) and digitized to disk onto a personal computer. The primary resolution of the camera was 1392 × 1040 pixels, although images were binned (2 × 2), resulting in a resolution of 696 × 520 pixels. The maximum image acquisition rate was 1.25 Hz. liquid handling was performed with an lc PAl autosampler (cTc Analytics, Zwingen, Switzerland) using a 100-µl syringe. A suite of labView 7.1 and 8.2.1 (national Instruments, Ireland) software routines written in the laboratory was used for hardware control, image acquisition data storage, and image analysis. The standard experimental protocol involved imaging each well twice: once in 25 µl control solution and once again 8 s after the injection of 50 µl naI test solution. Individual concentration responses were constructed by pooling results from 2 wells exposed to naI solution containing the same GABA or drug concentration. Each image typically contained 400 to 600 cells with sufficient fluorescence to be used for analysis. Experiments were replicated at least 3 times using cells transfected on different days. GABA concentration-response relationships were fitted with the following equation:
where F is the fluorescence corresponding to a particular GABA concentration, [GABA]; F init is the initial (or control) fluorescence value; Ec 50 is the concentration that elicits half-maximal activation; and nH is the Hill coefficient. A similar equation was used to fit inhibitory concentration-response relationships, with Ic 50 being the concentration that elicits half-maximal inhibition. curve fits were performed using a least squares fitting routine (Origin 7, Originlab corporation, northampton, MA). Statistical significance was determined by unpaired Student t-test with p < 0.05 representing significance. All averaged results are expressed as mean ± SEM.
Flow cytometry experiments
Samples were analyzed on a BD Biosciences (San Jose, cA) lSR II using a blue (488-nm) 20-mW laser source and a yFP (530/30BP) fluorescence collection filter. Approximately 10 4 events per cell population were analyzed using Weasel (WEHI, Parkville, Victoria, Australia) or FcS Express 3 (De novo Software, los Angeles, cA).
Pharmacological reagents
All pharmacological reagents, including GABA, bicuculline, diazepam, β-carboline methyl-4-ethyl-6,7-dimethoxy-β-carboline-3-carboxylate (DMcM), zolpidem, and zinc were obtained from Sigma.
RESULTS AND DISCUSSION
Comparison of expression efficiencies by flow cytometry
Flow cytometry was used to quantitate the percentage of cells successfully transfected with α1β1, α1β1γ1, and α1β1γ2 GABA A R subunit cDnA. GFP fluorescence was used as the transfection readout. The pIRES2-EGFP vector was used when transfecting α1 and β1 subunits without γ subunits. Thus, in these experiments, the fluorescence readout reflects the number of cells expressing either α1 or β1 subunits or both. When expressing trimeric receptors, α1 and β1 subunits were transfected in the pcDnA3.1 vector, whereas γ1 or γ2 subunits were transfected in the pIRES2-EGFP vector. Thus, in this case, the fluorescence readout reflects the number of cells expressing γ subunits. Figure 1A displays the percentage of transfected cells resulting from each of the 5 transfection protocols. Because Effectene and PolyFect yielded the highest expression efficiencies for all subunits, theoretically they should also produce the highest proportion of cells expressing trimeric α1β1γ GABA A Rs. Experiments designed to investigate this are now described.
Comparison of expression efficiencies by fluorescence imaging
We next compared transfection efficiencies by analyzing the transfected cells by conventional fluorescence microscopy. We first transfected cells with only the bicistronic vector containing γ1 and GFP cDnAs, then measured the number of fluorescent cells per well. Unlike flow cytometry, this technique cannot quantitate nonfluorescent cells. The results, presented in Figure 1B , reveal a similar transfection efficiency sequence as in Figure 1A . next we quantitated the number of fluorescent cells produced by transfection with yFP-I152l and the indicated GABA A R subunit combinations. As shown in Figure 1C , this yielded a similar rank order of transfection efficiencies. The third test involved assaying the number of fluorescent cells that were quenched by at least 20% following application of a saturating concentration (1 mM) of GABA. The result, summarized in Figure 1D , reveals the extent to which yFP-I152l and GABA A Rs are colocalized in individual cells. The same experiments were reanalyzed to reveal the average maximal quench observed for all fluorescent cells (Fig. 1E) . As γ subunits were invariably expressed in the pIRES-EGFP vector, it is likely that the magnitude of yFP quench was underestimated in Figure 1E due to contamination by fluorescence from environmentally insensitive GFP. Indeed, this contamination explains why percentage quench is systematically smaller in cells expressing γ subunits than in those expressing α1 and β1 subunits only. In control experiments, the mean GABA-mediated fluorescence quench in cells transfected with yFP-I152l alone was < 5% (not shown). Results from all 5 assays, summarized in Figures 1A-E , indicate that Effectene and PolyFect provide the most efficient means of transfecting HEK293 cells with yFP and GABA A R subunit cDnAs. However, functional analysis is required to determine whether these methods reliably produce trimeric GABA A Rs.
To address this, we took advantage of the fact that the γ1 subunit dramatically reduces the GABA sensitivity of αβ GABA A Rs. 9 Indeed, we recently showed by patch-clamp electrophysiology of identified cells that the mean GABA Ec 50 values of HEK293 cell-expressed α1β1 and α1β1γ1. GABA A Rs are 3.0 ± 0.6 and 22.4 ± 2.0 µM, respectively. 10 We, therefore, employed fluorescence quench to quantitate GABA concentrationresponse relationships of cells transfected with α1 and β1 subunits or α1, β1, and γ1 subunits via each of the 5 transfection conditions. The mean GABA Ec 50 values, displayed in Figure 1F , strongly suggest that Effectene and PolyFect produce the highest proportion of cells expressing α1β1γ1 GABA A Rs.
Pharmacology of γ subunit-containing receptors
To confirm this result and to determine whether this assay is suitable as a drug discovery tool, we characterized the pharmacological profiles of cells transfected via PolyFect with α1β1, α1β1γ1, and α1β1γ2 GABA A R subunits. In each experiment, GABA was applied at the Ec 30 concentration as given in Materials and Methods. The mean Ic 50 values of the antagonist, bicuculline, at α1β1, α1β1γ1, and α1β1γ2 GABA A Rs were 2.0 ± 1.1, 1.7 ± 0.7, and 1.3 ± 0.3 µM (n = 3 preparations each), respectively, which were not significantly different from each other by unpaired Student t-test (Fig. 2A) . This agrees with a previous study that showed γ subunits do not affect bicuculline sensitivity. Zinc produced a potent concentration-dependent inhibition of the α1β1 GABA A R with a mean Ic 50 of 8.6 ± 1.1 µM and an n H of 0.80 ± 0.07 (n = 3; Fig. 2B) . However, the zinc Ic 50 at both γ subunit-expressing receptors exceeded 1 mM. This agrees with previous studies that demonstrated that γ subunits confer zinc insensitivity to αβ GABA A Rs. 10, 12 To distinguish the pharmacological properties of α1β1γ1 and α1β1γ2 GABA A Rs, we investigated the effects of DMcM and zolpidem, both of which discriminate strongly between γ1-and γ2-containing receptors. DMcM potently inhibits γ2-containing GABA A Rs but has either no effect on or modestly potentiates γ1-containing GABA A Rs.
9,10,13,14 Zolpidem potentiates both γ1-and γ2-containing receptors but has much greater efficacy at γ2-containing GABA A Rs. 9, 10, 13, 14 The effects of zolpidem at 0.01-and 1-µM concentrations on α1β1, α1β1γ1, and α1β1γ2 GABA A Rs, determined using both the fluorescence assay and electrophysiology on identical receptors recombinantly expressed in HEK293 cells (reproduced from Esmaeili et al. 10 ), are presented in Figure 2C . The effects of 0.01 and 1 µM DMcM on all 3 receptors using both assays are shown in Figure 2D . The imaging and electrophysiology results for both assays are clearly highly consistent, indicating that PolyFect transfection reliably produces a large proportion of trimeric αβγ GABA A Rs.
Conclusions
We conclude that transfection of HEK293 cells with PolyFect or Effectene provides an efficient, reliable means of transiently expressing trimeric GABA A Rs in HEK293 cells. Fluorescence analysis of transfected cells using an anionquenchable yFP revealed dramatic differences in the pharmacological properties of γ1-and γ2-containing receptors that were consistent with previous electrophysiological results. These results validate these assays as a tool for identifying novel positive and negative GABA A R modulators. This method of expressing and screening recombinant GABA A Rs should provide an effective means of discovering novel GABA A R subunit-specific compounds for use as therapeutic lead compounds and pharmacological probes. 
